Cargando…
Optimizing Diagnosis of Urothelial Bladder Cancer with Blue Light Cystoscopy via Recognition of False-Positive Lesions
Introduction: Blue light cystoscopy (BLC) using hexaminolevulinate (Cysview(®)) improves the detection of nonmuscle invasive bladder cancer (NMIBC).(1–3) BLC results in lower recurrence rate and a better recurrence-free survival, as well as a progression benefit.(4) However, false-positive (FP) fluo...
Autores principales: | Bazargani, Soroush T., Djaladat, Hooman, Schuckman, Anne K., Hugen, Cory M., Daneshmand, Siamak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964243/ https://www.ncbi.nlm.nih.gov/pubmed/31976152 http://dx.doi.org/10.1089/vid.2017.0073 |
Ejemplares similares
-
Blue Light Cystoscopy with Cysview: The USC Experience
por: Bazargani, Soroush T., et al.
Publicado: (2016) -
Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases
por: Mitra, Anirban P., et al.
Publicado: (2022) -
The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol
por: Zainfeld, Daniel, et al.
Publicado: (2018) -
Multiparametric cystoscopy: is the future here yet?
por: Ahmadi, Hamed, et al.
Publicado: (2021) -
Hexaminolevulinate Blue-Light Cystoscopy in a Patient with Metastatic Melanoma of the Bladder
por: Shukla, Anant, et al.
Publicado: (2016)